当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2017年第4期
编号:13008260
氨硫脲片治疗喉结核的效果及对血清氧磷酶水平的影响(4)
http://www.100md.com 2017年2月5日 《中国医药导报》 2017年第4期
     [13] Gupta A,Nagaraja MR,Kumari PM,et al.Association of MDR-TB isolates with clinical characteristics of patients from Northern region of India[J].Indian J Med Microbiol,2014,32(3):270-276.

    [14] 王丽娜.不同雾化吸入方案治疗喉结核的临床效果与护理[J].河北医药,2013,35(20):3194-3195.

    [15] Kiakojuri K,Hasanjani Roushan MR.Laryngeal tuberculosis without pulmonary involvement[J].Caspian J Intern Med,2012,3(1):397-399.

    [16] Das S,Das D,Bhuyan UT,et al.Head and Neck Tuberculosis: Scenario in a Tertiary Care Hospital of North Eastern India[J].J Clin Diagn Res,2016,10(1):4-7.

    [17] 罗忠枚,夏小冬,崔玉彬,等.利福霉素类抗生素及其构效关系研究进展[J].中国抗生素杂志,2012,37(4):308-319.

    [18] Banerjee D,Bhattacharyya R.Isoniazid and thioacetazone may exhibit antitubercular activity by binding directly with the active site of mycolic acid cyclopropane synthase:Hypothesis based on computational analysis[J].Bioinformation,2012,8(16):787-789.

    [19] Hoa NB,Khanh PH,Chinh NV,et al.Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Vietnam[J].Trop Med Int Health,2014,19(9):1076-1081.

    [20] Dail MB,Pickin R,Crow JA,et al.The effect of in vitro dieldrin exposure on the rat paraoxonase 1 (pon1) promoter[J].J Biochem Mol Toxicol,2014,28(5):224-231.

    (收稿日期:2016-09-05 本文編辑:王雪), http://www.100md.com(徐红艳 高华 朱蕾)
上一页1 2 3 4